Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol GHRL contributors: mct/pgu - updated : 09-12-2016
HGNC name ghrelin/obestatin preprohormone
HGNC id 18129
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
constitutional     --over  
plasma ghrelin levels in children with PWS are elevated at any age, including during the first years of life, thus preceding the development of obesity
constitutional     --low  
low expression of ghrelin and GH, without causal relationship in obesity, and decreases under conditions of positive energy balance, such as feeding, hyperglycaemia and obesity
constitutional     --low  
in impaired glucose regulation (IGR) and type 2 diabetes mellitus (T2DM)
constitutional     --over  
increases under conditions of negative energy balance, such as starvation, cachexia and anorexia nervosa
tumoral     --over  
in modified prostatic epithelial cells (both hyperplastic or neoplastic) express higher levels of ghrelin than normal prostate
constitutional     --low  
in heart failure
constitutional     --over  
were associated with an increased risk of Barrett esophagus
constitutional     --over  
in young children with Prader-Willi Syndrome long before the onset of hyperphagia, especially during the early phase of poor appetite and feeding
constitutional     --over  
in children with growth hormone deficiency and neurosecretory dysfunction
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
cancerreproductiveprostate
application of specific inhibitors that block ghrelin signaling might provide new avenues for the design of better adjunctive therapies for prostate cancer
neurologyneurodegenerative 
may provide a novel therapeutic strategy for the treatment of disorders related to synaptic impairment
neuromuscularmyopathy 
potential role of GHRL/GPR39 for use as a therapeutic agent for the treatment of trauma-induced muscle injuries or skeletal muscle myopathies
ANIMAL & CELL MODELS